Cargando…
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response
BACKGROUND: Dialysis and kidney transplant patients with moderate-severe COVID-19 have a high mortality rate, around 30%, that is similar in the two populations, despite differences in their baseline characteristics. In these groups, the immunology of the disease has been poorly explored. METHODS: T...
Autores principales: | Alberici, Federico, Affatato, Stefania, Moratto, Daniele, Mescia, Federica, Delbarba, Elisa, Guerini, Alice, Tedesco, Martina, Burbelo, Peter D., Zani, Roberta, Castagna, Ilaria, Gallico, Agnese, Tonoli, Mattia, Venturini, Margherita, Roccaro, Aldo M., Giacomelli, Mauro, Cohen, Jeffrey I., Giustini, Viviana, Dobbs, Kerry, Su, Helen C., Fiorini, Chiara, Quaresima, Virginia, Viola, Fabio Battista, Vizzardi, Valerio, Gaggiotti, Mario, Bossini, Nicola, Gaggia, Paola, Badolato, Raffaele, Notarangelo, Luigi D., Chiarini, Marco, Scolari, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784230/ https://www.ncbi.nlm.nih.gov/pubmed/35067905 http://dx.doi.org/10.1007/s40620-021-01214-8 |
Ejemplares similares
-
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
por: Alberici, Federico, et al.
Publicado: (2020) -
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection
por: Alberici, Federico, et al.
Publicado: (2020) -
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia
por: Scolari, Francesco, et al.
Publicado: (2022) -
Flow Cytometry Identifies Risk Factors and Dynamic Changes in Patients with COVID-19
por: Moratto, Daniele, et al.
Publicado: (2020) -
The Authors Reply
por: Alberici, Federico, et al.
Publicado: (2020)